Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Randomized, Double Blind, Placebo Controlled Study of Curcumin to Reduce Mucositis in Autologous Transplant Setting

NCT04896164 is registered in ClinicalTrials.gov with Tata Memorial Centre as lead sponsor.

NCT NCT04896164
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04896164 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Randomized, Double Blind, Placebo Controlled Study of Curcumin to Reduce Mucositis in Autologous Transplant Setting
Lead sponsor
Tata Memorial Centre
Phase
Phase 3
Overall status
Unknown status
Start date
December 16, 2018
Completion date
May 16, 2025
Enrollment
190 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

oral mucositis (ulcerative)